Jason Cohen, Editor

About the Author Jason Cohen, Editor


Analysts Weigh in on Two Skyrocketing Stocks: Novadaq Technologies Inc. (NVDQ), Clovis Oncology Inc (CLVS)

Novadaq Technologies Inc. Novadaq Technologies Inc. (NASDAQ:NVDQ) shares are skyrocketing 95% to $11.70, following the …

Read more

Epizyme Inc (EPZM) Ends Positive After a Rollercoaster Ride; Oppenheimer Weighs in

Epizyme Inc (NASDAQ:EPZM) stock underwent a rollercoaster ride on Wednesday, eventually finishing positive at $12.35, nearly 11% …

Read more

Omeros Corporation’s Breakthrough Becomes a Clear Danger to Alexion: WBB

Omeros Corporation (NASDAQ:OMER) shares are on the rise after the drug maker announced that OMS721 has been …

Read more

Maxim Bullish on Zynerba Pharmaceuticals Inc (ZYNE) Following Meeting with Management

Many investors hope to win big on biotech stocks as shares can sky rocket when …

Read more

Canaccord Lifts Price Target on Valeant Pharmaceuticals Intl Inc (VRX), Cuts Endo International plc

Canaccord analysts are out with neutral standpoints on Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Endo …

Read more

Acorda Therapeutics Inc (ACOR): Key Takeaways from CVT-301 Presentation at MDS

Yesterday afternoon, Acorda Therapeutics Inc (NASDAQ:ACOR) presented data from its Phase 3 SPAN-PD clinical trial of …

Read more

bluebird bio Inc (BLUE) Leads the Way in the Next Wave of CAR-Ts

Cowen analyst Eric Schmidt is out today with a research note on shares of bluebird bio Inc …

Read more

Acorda Therapeutics Inc (ACOR) Is Undervalued for CVT-301’s Potential: Cowen

Acorda Therapeutics Inc (NASDAQ:ACOR) shares climbed nearly 10% to $16.80 in after-hours trading Monday, after …

Read more

ASCO: Puma Biotechnology Inc (PBYI) Receives Bullish Review from J.P. Morgan

J.P. Morgan’s Cory Kasimov is attending the annual American Society of Clinical Oncology, or ASCO, …

Read more

BTIG Shares Two Cents on Juno Therapeutics Inc (JUNO) Following ASCO Abstract

In a research report published Monday, BTIG analyst Dane Leone reiterated a Neutral rating on …

Read more